SMTL ID : 7d9q.1

Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with Compound 7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.66 Å

Oligo State

homo-dimer

Ligands

2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 4 residues within 4Å: Chain A: P.354, G.355, S.357, N.360 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.357, A:G.355 NAG-NAG-FUC.3: 6 residues within 4Å: Chain B: P.354, G.355, F.356, S.357, D.359, N.360 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:D.359 Hydrogen bonds: B:S.357, B:G.355

2 x H1R: (2S)-2-[[4-fluoranyl-1-[(3-fluorophenyl)methyl]piperidin-4-yl]methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one(Non-covalent)

H1R.2: 17 residues within 4Å: Chain A: Y.82, W.96, G.130, G.131, Y.134, Y.143, E.212, W.296, L.299, S.303, F.305, F.307, Y.347, F.348, Y.351, H.457, G.458 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:W.96, A:W.296, A:Y.347, A:F.348, A:Y.351, A:Y.351, A:Y.351 Hydrogen bonds: A:F.305 pi-Stacking: A:W.96, A:W.296 pi-Cation interactions: A:Y.347 H1R.4: 15 residues within 4Å: Chain B: Y.82, W.96, G.130, G.131, Y.134, Y.143, E.212, W.296, S.303, F.305, Y.347, F.348, Y.351, H.457, G.458 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:Y.347, B:F.348, B:F.348, B:Y.351, B:Y.351, B:Y.351 Hydrogen bonds: B:F.305 pi-Stacking: B:W.96, B:W.96, B:W.296

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhou, Y. et al., Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate. J.Med.Chem. (2021)

Release Date

2021-08-25

Peptides

Acetylcholinesterase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Acetylcholinesterase

Related Entries With Identical Sequence